Accuray Incorporated (ARAY)vsMedtronic PLC (MDT)
ARAY
Accuray Incorporated
$0.22
-3.54%
HEALTHCARE · Cap: $26.93M
MDT
Medtronic PLC
$88.64
+0.96%
HEALTHCARE · Cap: $114.23B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 9240% more annual revenue ($37.54B vs $401.95M). MDT leads profitability with a 13.9% profit margin vs -12.2%. MDT appears more attractively valued with a PEG of 1.63. MDT earns a higher WallStSmart Score of 68/100 (B-).
ARAY
Hold37
out of 100
Grade: F
MDT
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for ARAY.
Margin of Safety
+6.2%
Fair Value
$94.34
Current Price
$88.64
$5.70 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 40.7% YoY
Generating 1.3B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
Expensive relative to growth rate
ROE of -110.6% — below average capital efficiency
Expensive relative to growth rate
Grey zone — moderate risk
Comparative Analysis Report
WallStSmart ResearchBull Case : ARAY
The strongest argument for ARAY centers on Price/Book.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.
Bear Case : ARAY
The primary concerns for ARAY are Market Cap, Piotroski F-Score, PEG Ratio. Debt-to-equity of 4.41 is elevated, increasing financial risk.
Bear Case : MDT
The primary concerns for MDT are PEG Ratio, Altman Z-Score.
Key Dynamics to Monitor
ARAY profiles as a turnaround stock while MDT is a value play — different risk/reward profiles.
ARAY carries more volatility with a beta of 1.39 — expect wider price swings.
MDT is growing revenue faster at 13.7% — sustainability is the question.
MDT generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
MDT scores higher overall (68/100 vs 37/100) and 13.7% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Accuray Incorporated
HEALTHCARE · MEDICAL DEVICES · USA
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
Visit Website →Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?